Drug supply changes imminent

The U.S. government and other parties are stepping up efforts to protect the national drug distribution system from counterfeiting, terrorism and disruption from manmade and natural disasters, says a new report. Challenges include the dominance of three wholesalers, growth of mail order and the wave of pharmacy consolidation. "The U.S. supply chain is set to undergo great changes in the next decade," authors say. Summary

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.